Vendor review
Nexaph reviews
Nexaph reviews from 295 independent lab tests (Retatrutide, Tirzepatide and Tesamorelin): grade A, purity and fill accuracy. Is Nexaph legit? See what its vials showed.
What the lab tests show
295 tests on record, newest first. Scores are purity divided by ten.
| Date | Product | Purity | Quantity | Identity | Certificate |
|---|---|---|---|---|---|
| Oct 9, 2026 | GHK-Cu | 99.9 % | 49.99 mg of 50 mg (0 %) | Pass | View |
| Oct 1, 2026 | BPC-157 | 99.9 % | 9.99 mg of 10 mg (0 %) | Pass | View |
| Sep 25, 2026 | MOTS-c | 99.9 % | 11.2 mg of 10 mg (12 %) | Pass | View |
| Sep 24, 2026 | BPC-157 | 99.6 % | 11.6 mg of 10 mg (16 %) | Pass | View |
| Sep 24, 2026 | Tirzepatide | 99.9 % | 20.7 mg of 20 mg (3 %) | Pass | View |
| Sep 20, 2026 | Tirzepatide | 98.25 % | 11.94 mg of 10 mg (19 %) | Pass | View |
| Sep 18, 2026 | BPC-157 | 99.99 % | 10.48 mg of 10 mg (5 %) | Pass | View |
| Sep 16, 2026 | Tesamorelin | 99.8 % | 12.3 mg of 10 mg (23 %) | Pass | View |
| Sep 16, 2026 | Retatrutide | 99.9 % | 55 mg of 48 mg (15 %) | Pass | View |
| Sep 15, 2026 | Retatrutide | 99.8 % | 6.72 mg of 6 mg (12 %) | Pass | View |
| Sep 14, 2026 | Cagrilintide | 98 % | 7.64 mg of 5 mg (53 %) | Pass | View |
| Sep 10, 2026 | Tirzepatide | 99.9 % | 10.4 mg of 10 mg (4 %) | Pass | View |
| Sep 10, 2026 | Tirzepatide | 99.9 % | 30.5 mg of 30 mg (2 %) | Pass | View |
| Sep 10, 2026 | Tesamorelin | 99 % | 9.53 mg of 10 mg (-5 %) | Pass | View |
| Sep 9, 2026 | Retatrutide | 99.9 % | 10 mg of 12 mg (-17 %) | Pass | View |
| Sep 4, 2026 | CJC-1295 | 99.7 % | 4.86 mg of 5 mg (-3 %) | Pass | View |
| Aug 27, 2026 | Tirzepatide | 97.24 % | 17.41 mg of 15 mg (16 %) | Pass | View |
| Aug 13, 2026 | MOTS-c | 98.5 % | 10.1 mg of 10 mg (1 %) | Pass | View |
| Aug 9, 2026 | Tirzepatide | 99.8 % | 17.2 mg of 15 mg (15 %) | Pass | View |
| Aug 4, 2026 | Tirzepatide | 99.9 % | 59.9 mg of 60 mg (0 %) | Pass | View |
| Jul 21, 2026 | Tirzepatide | 99.9 % | 35.3 mg of 30 mg (18 %) | Pass | View |
| Jul 20, 2026 | Retatrutide | 99.9 % | 11.6 mg of 12 mg (-3 %) | Pass | View |
| Jul 17, 2026 | MOTS-c | 98.1 % | 10.2 mg of 10 mg (2 %) | Pass | View |
| Jul 13, 2026 | Retatrutide | 98.7 % | 14.3 mg of 12 mg (19 %) | Pass | View |
| Jul 1, 2026 | Retatrutide | 99.9 % | 27.1 mg of 24 mg (13 %) | Pass | View |
| Jul 1, 2026 | Tesamorelin | 98.3 % | 12.7 mg of 10 mg (27 %) | Pass | View |
| Jun 26, 2026 | Tirzepatide | 99.8 % | 17.5 mg of 15 mg (17 %) | Pass | View |
| Jun 26, 2026 | Retatrutide | 99.8 % | 29.5 mg of 24 mg (23 %) | Pass | View |
| Jun 26, 2026 | GHK-Cu | 99.6 % | 58.3 mg of 50 mg (17 %) | Pass | View |
| Jun 16, 2026 | Tesamorelin | 93.1 % | 10.7 mg of 10 mg (7 %) | Pass | View |
| Jun 16, 2026 | GHK-Cu | 99.9 % | 52.7 mg of 50 mg (5 %) | Pass | View |
| Jun 15, 2026 | Tirzepatide | 99.9 % | 27.3 mg of 30 mg (-9 %) | Pass | View |
| Jun 15, 2026 | Tirzepatide | 99.9 % | 27.5 mg of 30 mg (-8 %) | Pass | View |
| Jun 12, 2026 | Tirzepatide | 99.9 % | 29.2 mg of 30 mg (-3 %) | Pass | View |
| Jun 12, 2026 | Retatrutide | 99.7 % | 20.5 mg of 20 mg (2 %) | Pass | View |
| Jun 12, 2026 | CJC-1295 | 99.9 % | 4.34 mg of 5 mg (-13 %) | Pass | View |
| Jun 12, 2026 | BPC-157 | 99.9 % | 10.4 mg of 10 mg (4 %) | Pass | View |
| Jun 6, 2026 | Ipamorelin | 99.8 % | 10.5 mg of 10 mg (5 %) | Pass | View |
| Jun 2, 2026 | Retatrutide | 99.9 % | 11.8 mg of 12 mg (-2 %) | Pass | View |
| Jun 1, 2026 | Retatrutide | 99.9 % | 10.7 mg of 10 mg (7 %) | Pass | View |
| Jun 1, 2026 | NAD+ | 99.9 % | 297.1 mg of 250 mg (19 %) | Pass | View |
| May 27, 2026 | NAD+ | 98.1 % | 494 mg of 500 mg (-1 %) | Pass | View |
| May 25, 2026 | Retatrutide | 99.8 % | 11 mg of 10 mg (10 %) | Pass | View |
| May 20, 2026 | Tesamorelin | 99.9 % | 11.4 mg of 10 mg (14 %) | Pass | View |
| May 20, 2026 | MOTS-c | 98.8 % | 9.07 mg of 10 mg (-9 %) | Pass | View |
| May 19, 2026 | Retatrutide | 99.9 % | 6.65 mg of 6 mg (11 %) | Pass | View |
| May 19, 2026 | Retatrutide | 99.9 % | 10.8 mg of 10 mg (8 %) | Pass | View |
| May 13, 2026 | GHK-Cu | 99.9 % | 98.8 mg of 100 mg (-1 %) | Pass | View |
| May 11, 2026 | Tirzepatide | 99.9 % | 62 mg of 60 mg (3 %) | Pass | View |
| May 8, 2026 | Retatrutide | 99.9 % | 46.6 mg of 48 mg (-3 %) | Pass | View |
| May 8, 2026 | Retatrutide | 99.9 % | 12.5 mg of 12 mg (4 %) | Pass | View |
| May 8, 2026 | GHK-Cu | 99.8 % | 56.1 mg of 50 mg (12 %) | Pass | View |
| May 6, 2026 | Tirzepatide | 99.9 % | 33.6 mg of 30 mg (12 %) | Pass | View |
| May 6, 2026 | Retatrutide | 99.9 % | 24.5 mg of 24 mg (2 %) | Pass | View |
| May 5, 2026 | GHK-Cu | 99.9 % | 107 mg of 100 mg (7 %) | Pass | View |
| Apr 30, 2026 | TB-500 | 99.5 % | 8.6 mg of 10 mg (-14 %) | Pass | View |
| Apr 28, 2026 | Tirzepatide | 99.9 % | 15.9 mg of 15 mg (6 %) | Pass | View |
| Apr 28, 2026 | Retatrutide | 99.9 % | 6.23 mg of 6 mg (4 %) | Pass | View |
| Apr 28, 2026 | Tesamorelin | 99.9 % | 9.97 mg of 10 mg (0 %) | Pass | View |
| Apr 28, 2026 | MOTS-c | 98.2 % | 10 mg of 10 mg (0 %) | Pass | View |
What Nexaph sells
Current listings from the vendor's own store, by peptide.
Wolverine Stack
from $1.61/mg| Size | Price | Per mg | Stock | |
|---|---|---|---|---|
| 100 mg (10 vials) | $1.88/mg | In stock | View | |
| 200 mg (10 vials) | $1.61/mg | In stock | View |
About Nexaph
Finnrick has tested 295 samples from Nexaph across 15 products.